- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/708 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
Patent holdings for IPC class A61K 31/708
Total number of patents in this class: 459
10-year publication summary
|
39
|
38
|
43
|
46
|
38
|
32
|
48
|
42
|
27
|
10
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alios BioPharma, Inc. | 69 |
22 |
| Idenix Pharmaceuticals LLC | 66 |
12 |
| Centre National de La Recherche Scientifique | 9632 |
9 |
| Merck Sharp & Dohme LLC | 3689 |
9 |
| Gilead Sciences, Inc. | 1879 |
8 |
| Stagen Co., Ltd. | 15 |
8 |
| Janssen Biopharma, Inc. | 52 |
8 |
| The Board of Regents of the University of Texas System | 2043 |
7 |
| Janssen Pharmaceuticals, Inc. | 399 |
6 |
| Abbott Laboratories | 2542 |
6 |
| The Trustees of Columbia University in the City of New York | 3440 |
6 |
| Atea Pharmaceuticals, Inc. | 65 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
5 |
| Idenix Pharmaceuticals, Inc. | 50 |
5 |
| President and Fellows of Harvard College | 5792 |
4 |
| Ligand Pharmaceuticals Incorporated | 121 |
4 |
| N.V. Nutricia | 1022 |
4 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1338 |
4 |
| Zogenix, Inc. | 44 |
4 |
| Ultupharma AB | 11 |
4 |
| Other owners | 319 |